chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received on 04-JUN-2018 regarding a case in litigation from a lawyer and a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about October 2014, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route at a pharmacy for routine health maintenance and for the prevention of shingles. The vaccine did not prevent shingles but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after receiving ZOSTAVAX, the patient experienced feeling of dizziness and feeling lightheaded and developed painful blisters on her neck. Thereafter, the patient presented to her primary care physician and was diagnosed with shingles, which lead to severe scarring throughout her body. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. It is claimed the patient sustained pain and suffering for severe and permanent personal injuries. Severe scarring throughout her body, dizziness and feeling lightheaded and persistent strain of herpes zoster/shingles were considered to be disabling. Additional information has been requested.
It was reported that a woman, who was 38 years old at the time of reporting, was administered a dose of Typhoid vaccine in her left arm on 26-May-97. The day following vaccination, the pt presented with injected arm sensitive and motor paralysis, that lasted for one week. The pt could work, but she could not drive her car. She was treated with aspirin. Pt recovered. A previous Typhoid vaccination had been well tolerated. The reporter considered the case as serious (for seriousness criteria: disability). Further information is awaited. File to be completed.
Child moved here from another state getting enrolled in school. Received shots 3/19/08 prior to move. These shots were not noticed until after client had left. Received additional TD and IPV. Mother notified by telephone. To call nurse if child had any local reactions. No reactions reported.
nausea, dizziness, headache, entire body achy-muscles hurt, fatigue night of sot and entire next day. Gone Sunday morning.
Hives; Left arm 0.3mL/ sore ness on the arm Left; This is a spontaneous report from a contactable consumer (patient). A 42-year-old (also reported as "41") female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248, Expiry Date: 30Apr2021, 3 mcg/ml), via an unspecified route of administration on 08Jan2021 08:40 at 0.3 mL, single dose at left arm ("Dosage text: Left arm 0.3mL") for COVID-19 immunization. Medical history included asthma. Concomitant medication included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA, reported as "BREO") for asthma. The patient was given 0.3mL, 30mcg of the COVID vaccine. The patient experienced sore ness on the arm left on 08Jan2021 and hives on 09Jan2021. She is calling about the Covid Vaccine, she got it on Friday 08Jan2021 at 8:40AM and she went home got soreness in arm (began the same day), it was a couple hours after at 10 or 11 and it stopped on Sunday 10Jan2021. She took pain killers. She woke up Saturday morning, and her whole body has broken out in hives, she has been taking Benadryl around the clock. She broke out in hives on 09Jan2021, it is still ongoing, its in between, she is still scratching and taking the Benadryl. Therapeutic measures were taken as a result of the events which included pain killers and Benadryl. The outcome of the event sore ness on the arm left was recovered on 10Jan2021, of hives was not recovered. She has never had a positive test for COVID prior to the vaccine. She has had an Antibody test 4 times and each time it was negative, she had her last antibody test in Nov2020. She has had no issues with vaccines in the past.
Information has been received from a nurse practitioner referring to 4 year old female patient with no known drug allergy. The patient had no illness at time of vaccination. The patient's birth weight was 7lb 8oz and has three siblings. Concomitant therapies included (Oka/Merck) VARIVAX and KINRIX. On 23-MAY-2016 at 16:15, the patient was vaccinated with (wistar ra 27-3) M-M-R II (rHA lot # L032044  dose 2, subcutaneously in the left thigh). The vaccine was properly stored at 53.2 F for 9 hours and 25 minutes. There were no previous temperature excursions. Digital data logger was involved. No adverse effect was reported. This is one of several reports received rom the same reporter. Additional information has been requested.
Initially just the side effects that are expected, but then I ended up with a sinus infection that was treated with Amoxacillin followed by Doxacillin, but it moved from my sinuses to my lungs.  Currently on prednisone and taking albuterol supplemental inhaler.  I continue with productive cough that won't go away and I'm very fatigued.
Patient describes frequent bouts of diarrhea  with associated weakness and lightheadedness, symptoms started 05/08/21, he had received the Jand J vaccine 05/05/21
ED visit for dehydration - treated and released. Normal labor and delivery on male weighing 3.36 kg (7 lb 6.5 oz). Hospital admission within 6 weeks of receiving the COVID vaccine.
My child was speaking very clearly, had a large vocabulary, and was starting to speak in sentences. Within 3 days of receiving this vaccine, she stopped speaking altogether. It has now been over 2 months and she has just started to use a few words. This is not normal.
Patient with history of cerebral palsy, diabetes.  He was brought to the ED by EMS on 11/30/22 for evaluation of a fever. Patient lives in a group home and EMS was called after staff noticed patient's lack of alertness compared to baseline. Fever was 102 F, patient found to be hypoxic. COVID-19 PCR test performed in the ED on 11/30 and found to be positive. Ultimately patient admitted 11/30/22 - 12/5/22 for sepsis secondary to COVID-19 infection. Patient was on supplemental O2, however was able to be weaned off.
He had a slight seizure and frozed up on the chair 5 minutes after administering his Moderna vaccine.  Called ambulance and his vitals checked out fine and he did not have to go to the hospital .  After about 15-20 min. he left on his own.
Swelling in armpit on left arm, small dime size swelling in collar bone left side
Golf ball sized nodule underneath the left armpit; This spontaneous case was reported by a pharmacist and describes the occurrence of AXILLARY MASS (Golf ball sized nodule underneath the left armpit) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 07-May-2021, the patient experienced AXILLARY MASS (Golf ball sized nodule underneath the left armpit). At the time of the report, AXILLARY MASS (Golf ball sized nodule underneath the left armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provider by the reporter.  Treatment information was not provided.
No adverse event; Moderna doses on 29Apr2021 and 21May2021; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna doses on 29Apr2021 and 21May2021) and NO ADVERSE EVENT (No adverse event) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna doses on 29Apr2021 and 21May2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna doses on 29Apr2021 and 21May2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna doses on 29Apr2021 and 21May2021).    Concomitant medication was not reported.  It was reported that, patient received previous COVID-19 vaccination doses of Moderna on 29-Apr-2021 and 21-May-2021. Treatment medication was not reported.   This case was linked to MOD-2023-705025 (Patient Link).
Right eye began to burn almost immediately, followed by clear runny nasal discharge, plus left eye burning.  8 hours later, my hands, feet and nose became ice cold, head ached, arm began to hurt. Restless night, low grade fever. Progressed within 48 hours to epigastritis, intractable nausea?started Omeprazole on 3/11.  Exhaustion lasted until Day 10 when I began to feel better and the nausea finally lifted. I do not want to go through this a second time but an asking you for guidance. I desperately want released from house confinement and separation from my children and grandchildren. Please help me with a decision of whether of not to take the second dose.
This spontaneous report as received from a health professional refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history, concomitant conditions and concomitant medications was provided. On unknown (unspecified) dates, improperly stored doses of GARDASIL (lot # K007264, expiration date: 02-MAR-2017, dose, route of administration and injection site were not reported) were administered to an unspecified number of unspecified patients. Administered doses of GARDASIL underwent temperature excursions at 32 Fahrenheit degrees, for 12 hours. Information about the previous temperature excursions was not reported. No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
10 days after injection, woke up at 4am on 1/20/21 with intense lower abdominal pain near pubic bone, tenesmus,diarrhea,  stools- white  mucous with blood, headache, chills, fatigue. Temperature 99.5
Hospitalized with COVID 19 12.9.22 - 12.29.22 (fully vaccinated and booster received)  Discharge Provider: MD  Primary Care Provider: DO    Admitting Service: Internal Medicine Service Admission Date: 12/9/2022 Discharge Date: 12/29/2022 Admitting Diagnoses: Acute respiratory failure due to COVID-19 (HCC) Patient Active Problem List Diagnosis ? Stage 3a chronic kidney disease (HCC) ? Lewy body dementia without behavioral disturbance (HCC) ? Prostate cancer (HCC) - MUSIC ? Other dysphagia ? Moderate episode of recurrent major depressive disorder (HCC) ? Primary osteoarthritis involving multiple joints ? Dementia with behavioral disturbance ? Advance care planning ? Multiple comorbid conditions ? Other constipation Details of Hospital Stay PRESENTING PROBLEM:  Acute respiratory failure due to COVID-19 (HCC) [U07.1, J96.00] HOSPITAL COURSE: 85-year-old male with history of prostate cancer, CKD stage 3, coronary disease, hyperlipidemia, Lewy body dementia with parkinsonism.  Admitted for hypoxia with COVID.  Patient was started on Remdesivir(4 doses completed on 12/12) and Decadron(10 doses completed on 12/19/2022).  Blood cultures remain negative.  Chest x-ray was negative for acute cardiopulmonary disease. Patient on room air and doing well from respiratory standpoint. Patient did have episodes of confusion and agitation, which improved with the use of Seroquel. SLP evaluated the patient and a video swallow study showed that he is aspirating across all consistencies and they recommended a feeding tube.  Wife wanted a percutaneous tube due to feeling that this might be long-term problem due to progressing dementia.  In the meantime Corpak was placed and he tolerated tube feeds.  IR placed PGJ on 12/19.  Tolerated tube feeds well, initial plan was for long-term care facility, eventually his strength improved, PT and OT recommended home care, Care Management during home PT/OT/SLP and Nutrition Services, instructions discussed in detail with patient's wife, she verbalized understanding, discharge home today in stable condition.
Sore arm approximately 4 hours post. Severe chills began 10 hours post, progressed to fever ranging 100.7 to 101. Nausea started at 11 hours post, and persistent vomiting began 15 hours post. Vomiting stopped 20 hours post and others symptoms began to abate at 24 hours post. Ibuprofen was tolerated at that point and fever, headache and chills dissipated by 30 hours post. Resumed normal activity (with rest breaks needed) 48 hours post. Injection site remains sore but anticipated to resolve within next 24-48 hours. Doctor notified this am (three days from injection).
Patient was given Moderna 1st shot accidentally; A spontaneous report was received from a consumer's mother concerning female patient who received Moderna's COVID-19 vaccine (mRNA-1273) accidentally.   The patient's medical history was not provided.  Concomitant product use was not provided.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection.    On the unknown date the patient was accidentally administered the vaccine.  The mother was concerned whether she should be administered the Moderna vaccine for the second dose or try the Pfizer vaccine at this point.  She is also asking to see if her daughter can be enrolled in Moderna's teen clinical trial.  Action taken with second dose of mRNA-1273 in response to the events was not reported.   The event, was accidentally given Moderna first shot was considered resolved.; Reporter's Comments: This case concerns a female patient who received their first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection. There were no reported adverse events after the vaccine was administered in this case of product administered to patient of inappropriate age
Expired Kinrix administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 4-year-old female patient who received DTPa-IPV (Kinrix) (batch number E2L54, expiry date 03-MAR-2023) for prophylaxis.   On 14-MAR-2023, the patient received Kinrix. On 14-MAR-2023, an unknown time after receiving Kinrix, the patient experienced expired vaccine used (Verbatim: Expired Kinrix administered). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14-MAR-2023 A nurse informed that earlier that day, a dose of Kinrix that had expired and was administered to a patient, which led to expired vaccine used. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
Small scaly rash on left shoulder which is very itchy! Rash continues to spread to chest also very itchy! Researched rash as pityriasis rosea because it has all the characteristics of what has been occurring! The herald Patch continue to be the itchiest!
My blood pressure went up for no apparent reason. Nothing had changed. Last week it happened - about 20 days later after vaccine. It was 152/100 when I took it in the morning. I was feeling chest pressure - it was 7 or 8 on pain scale. I went to ER. No treatment at hospital and they didn't send me home with any treatment. They told me to see my PCP. I went to health network this morning and the PA said that I needed to see another doctor and she will probably send me to a Cardiologist to get a stress test. My internal med wants me to take thyroid test and electrolyte test. I am still having chest pressure but it is hardly noticeable - it's more at 1 or 2 now for pain scale. It's like a bar right above my tummy - like a 2 inch by 4 inch area - like a pressure on it. My blood pressure has been going down lately. This morning it was more normal - 128/82. Right after the vaccine dose - my joints were aching for 5 days; my finger joints were locking. I have a chronic inflammation on my left foot and after the vaccine, my left foot swelled up. And I was tired and I thought I had a fever.
Information has been received from a certified medical assistant referring to an unspecified number of patients of unknown age and gender. There was no medical history or drug reaction/allergies reported. On unknown dates the patients were vaccinated with doses of improperly stored GARDASIL (lot # K004205 with expired date 12-JAN-2017, dose and route were unknown). No concomitant therapy was provided. No adverse effect was reported. Additional information has been requested.
blood pressure drop, blood sugar low, felt dizzy, ears ringing, vision blurring;felt nausea;lasted approx 1hr;
Symptoms began 05/02/2023, muscle aches, fever, UTI  and fatigue. Case tested positive 05/05/20223 at hospital. Was admitted 05/06/2023.
I became dizzy, short of breath and chest tightness on May 5th in the afternoon. I first called my DR who told me to go to the ER. They did the CAT Scan, Blood test. CAT scan showed all clots resolved. I was admitted since the reason for my symptoms could not be identified. The did chemical stress test which came back normal. They sent me home on the following day, the 6th. I followed up with my PCP and pulmonologist. I am also going to follow up with a cardiologist.
I have had mild tinnitus for years. After the vaccine first shot it became much louder and constant. I also developed some vertigo symptoms that have persisted since the shot.
pt vax w/ hepta B on 14Dec90; Later exp fever 102F for half day. MD dx as viral synd not related to vax;
got the first dose on 23Jun2021 and has not got second dose yet.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (got the first dose on 23Jun2021 and has not got second dose yet.) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first dose on 23Jun2021 and has not got second dose yet.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (got the first dose on 23Jun2021 and has not got second dose yet.) outcome was unknown.            patient reported Moderna vaccine first dose on 23Jun2021 and has not gotten the second dose yet. Caller inquires if they should start over the series or get the second dose now, Caller inquires where they could get the Moderna vaccine near their home.  No Medical History Reported. No Concomitant medication Reported
Later that night and for a week now, I've thrown up and felt nauseated and or had stomach pain. I also had/have headaches and migraines all week. I didn't not have a stomach ache at the time of injection. I also was given a flu shot as well in the left arm.
sore arm, feels warm, is red around injection site, itches, hardness in the muscle
wilhout any adverse symptoms; A patient in their office today received a dose of PROQUAD and MMRII instead of just PROQUAD.; A patient in their office today received a dose of PROQUAD and MMRII instead of just PROQUAD.; This spontaneous report was received from a medical assistant, referring to a 46 year old female patient. The information regarding patient's medical history, concurrent conditions, concomitant medications were not provided.  On 12-AUG-2020, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (dose 0.5ml, lot # S015428 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 20-MAY-2021, albumin status rHA (recombinant Human albumin), concentration, frequency and route were unknown) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (dose 0.5ml, lot #S021619 has been verified to be a valid lot number, expiration date not reported, but upon internal validation established as 09-JAN-2021, albumin status rHA (recombinant Human albumin), concentration, frequency and route were unknown) instead of just measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) for prophylaxis (inappropriate schedule of product administration and product administered to patient of inappropriate age). The patient was without any adverse symptoms as of now per the medical assistant.
Nothing really for first few days. On day two felt balance problem, insomnia day's 1 and 2. Day 4 stuffed nose, slight cough. Tired during day long nap. Day 5 experiencing dizziness. Not vertigo, just heavy head, dizziness and slight chills. Thought about going to ER, but felt a bit better an hour later. So far lasted for a few hours. No fever.
3 weeks after the second Pfizer shot at 10:38 pm my smell and taste came back almost 100%.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3249) via intramuscular route of administration in the right arm on 09Jan2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included olmesartan medoxomil (BENICAR) and nebivolol hydrochloride (BYSTOLIC) both for unknown indications, from an unknown dates and unknown if ongoing. The patient previously received ZICAM (nasal spray) on an unknown date in 1998 and experienced loss of smell and loss of taste. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 19Dec2020 at 13:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. The patient reported that she had once used in late 1998 over the counter nasal spray ZICAM. Since then, she had lost smell and taste. On 29Jan2021, at 22:38 three weeks after the second Pfizer shot, her smell and taste came back almost 100%. She had lost some smell and taste but continued to have what had been gone. She would pay for a shot like this to continue to smell and taste. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event three weeks after the second Pfizer shot, her smell and taste came back almost 100% was unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a friend of a friend's 11 or 12 year old daughter who on approximately 04-MAR-2007 ("about 1 month ago") was vaccinated with a first dose of Gardasil. In approximately March 2007, the patient developed Stevens-Johnson Syndrome and was hospitalized. Her recovery status was unknown at the time of the report. Additional information has been requested.